Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of Pomalidomide, Oral Dexamethasone and Very Low-dose Cyclophosphamide in Patients With Refractory Multiple Myeloma Who Have Received Lenalidomide and Bortezomib

Maimónides Biomedical Research Institute of Córdoba · 2017
ClinicalTrials.gov · Datasets · License: Public Domain · 2017
Open Source ↗
multiple-myeloma
multiple myeloma, pomalidomide, cyclophosphamide, dexamethasone, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 912483
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.